# Zhejiang Liaoyuan Pharmaceutical Co., Ltd. – FDA Inspection, Aug 25, 2023

Source: https://www.keypedia.com/records/fda_inspections/zhejiang-liaoyuan-pharmaceutical-co-ltd/e8db4578-8be6-4f31-bde9-486ef7e45a47
Source feed: FDA_Inspections

> FDA inspection 1217646 of Zhejiang Liaoyuan Pharmaceutical Co., Ltd., August 25, 2023. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1217646
- Company Name: Zhejiang Liaoyuan Pharmaceutical Co., Ltd.
- Inspection Date: 2023-08-25
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1019163 - 2017-06-09](https://www.keypedia.com/records/fda_inspections/zhejiang-liaoyuan-pharmaceutical-co-ltd/9755a0a7-acdb-40c0-92a1-b296912c46cc)

## Related Officers

- [Wayne D. Mcgrath](https://www.keypedia.com/people/wayne-d-mcgrath/42db5ab0-2e0b-4909-951c-e7621cd04f6e)

Company: https://www.keypedia.com/companies/zhejiang-liaoyuan-pharmaceutical-co-ltd/5e084d5d-74f8-495e-960b-072dabe6a6a6

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c